Chih Hui Cheng
Chief Executive Officer bei ONENESS BIOTECH CO., LTD.
Vermögen: 4 Mio $ am 31.03.2024
Profil
Chih Hui Cheng is currently the Director-Supervisory Board at Microsoy International, Inc., the Director at Stemcyte Taiwan, the General Manager at Oneness Biotech Co., Ltd., and a Member-Supervisory Board at Tetanti Agribiotech, Inc. In the past, Mr. Cheng worked as the Director, Assistant Manager-Finance & IR Contact at Microbio Co., Ltd.
and as a Member-Supervisory Board at Sinew Pharma, Inc. Mr. Cheng completed their undergraduate degree at the University of Tamkang.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.08.2022 | 643 760 ( 0,14% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Chih Hui Cheng
| Unternehmen | Position | Beginn |
|---|---|---|
| ONENESS BIOTECH CO., LTD. | Chief Executive Officer | 21.06.2018 |
Microsoy International, Inc.
 Microsoy International, Inc. Pharmaceuticals: OtherHealth Technology Microsoy International, Inc. develops nutrition and health care products. The private company is based in Taipei, Taiwan. | Director/Board Member | 12.11.2010 |
Tetanti Agribiotech, Inc.
 Tetanti Agribiotech, Inc. Medical SpecialtiesHealth Technology Tetanti Agribiotech, Inc. manufactures enzyme processing equipment, and provides biotechnology services. The company was founded by Qiu Zhong Yang on June 25, 2018 and is headquartered in Taichung, China. | Director/Board Member | - |
Stemcyte Taiwan
 Stemcyte Taiwan Medical/Nursing ServicesHealth Services Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts. | Director/Board Member | - |
Ehemalige bekannte Positionen von Chih Hui Cheng
| Unternehmen | Position | Ende |
|---|---|---|
| SINEW PHARMA INC. | Director/Board Member | - |
| MICROBIO CO., LTD. | Director of Finance/CFO | - |
Ausbildung von Chih Hui Cheng
| University of Tamkang | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MICROBIO CO., LTD. | Health Technology |
| ONENESS BIOTECH CO., LTD. | Health Technology |
| SINEW PHARMA INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Microsoy International, Inc.
Microsoy International, Inc. Pharmaceuticals: OtherHealth Technology Microsoy International, Inc. develops nutrition and health care products. The private company is based in Taipei, Taiwan. | Health Technology |
Stemcyte Taiwan
Stemcyte Taiwan Medical/Nursing ServicesHealth Services Stemcyte Taiwan, founded in 2000, is a private company based in New Taipei City, Taiwan that specializes in umbilical cord blood banking. Stemcyte Taiwan has been recognized by over 350 medical centers worldwide and has helped with over 2,500 cord blood transplants. The Taiwanese company has a large public cord blood bank and exclusive patent technology for red blood cell separation. Stemcyte Taiwan has received international accreditations from AABB, FACT, NMDP, WMDA, and FDA, providing customers with secure and transparent contracts. | Health Services |
Tetanti Agribiotech, Inc.
Tetanti Agribiotech, Inc. Medical SpecialtiesHealth Technology Tetanti Agribiotech, Inc. manufactures enzyme processing equipment, and provides biotechnology services. The company was founded by Qiu Zhong Yang on June 25, 2018 and is headquartered in Taichung, China. | Health Technology |
